1. Home
  2. SPCB vs LSTA Comparison

SPCB vs LSTA Comparison

Compare SPCB & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • LSTA
  • Stock Information
  • Founded
  • SPCB 1988
  • LSTA 1980
  • Country
  • SPCB Israel
  • LSTA United States
  • Employees
  • SPCB N/A
  • LSTA 26
  • Industry
  • SPCB Semiconductors
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • SPCB Technology
  • LSTA Health Care
  • Exchange
  • SPCB Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • SPCB 53.3M
  • LSTA 22.5M
  • IPO Year
  • SPCB N/A
  • LSTA N/A
  • Fundamental
  • Price
  • SPCB $10.70
  • LSTA $2.72
  • Analyst Decision
  • SPCB Strong Buy
  • LSTA Strong Buy
  • Analyst Count
  • SPCB 1
  • LSTA 1
  • Target Price
  • SPCB $18.00
  • LSTA $15.00
  • AVG Volume (30 Days)
  • SPCB 129.8K
  • LSTA 23.4K
  • Earning Date
  • SPCB 08-14-2025
  • LSTA 08-11-2025
  • Dividend Yield
  • SPCB N/A
  • LSTA N/A
  • EPS Growth
  • SPCB N/A
  • LSTA N/A
  • EPS
  • SPCB 1.89
  • LSTA N/A
  • Revenue
  • SPCB $27,831,000.00
  • LSTA $1,000,000.00
  • Revenue This Year
  • SPCB $2.73
  • LSTA N/A
  • Revenue Next Year
  • SPCB $22.87
  • LSTA N/A
  • P/E Ratio
  • SPCB $5.55
  • LSTA N/A
  • Revenue Growth
  • SPCB 2.90
  • LSTA N/A
  • 52 Week Low
  • SPCB $2.55
  • LSTA $1.87
  • 52 Week High
  • SPCB $18.95
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 55.03
  • LSTA 52.43
  • Support Level
  • SPCB $9.23
  • LSTA $2.34
  • Resistance Level
  • SPCB $10.97
  • LSTA $3.09
  • Average True Range (ATR)
  • SPCB 0.61
  • LSTA 0.25
  • MACD
  • SPCB -0.11
  • LSTA 0.01
  • Stochastic Oscillator
  • SPCB 65.97
  • LSTA 50.67

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: